Leigh-type neuropathology in Pearson syndrome associated with impaired ATP production and a novel mtDNA deletion

Neurology

Volumn 47, Issue 5, 1996, Pages 1320-1323

  Santorelli, F M ^a   Barmada, M A ^b   Pons, R ^a   Zhang, L L ^a   DiMauro, S ^a,c  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; CYTOCHROME C OXIDASE; MITOCHONDRIAL DNA; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE);

ARTICLE; CASE REPORT; CONTROLLED STUDY; ENCEPHALOMYOPATHY; ENZYME DEFICIENCY; GENE DELETION; HUMAN; HUMAN CELL; HUMAN TISSUE; INFANT; LEIGH DISEASE; MALE; NEUROPATHOLOGY; OXIDATIVE PHOSPHORYLATION; PEARSON SYNDROME; PRIORITY JOURNAL; RESPIRATORY CHAIN; SKIN FIBROBLAST;

EID: 0029854881     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.47.5.1320     Document Type: Article

References (15)

1. Shoffner JM, Wallace DC. Oxidative phosphorylation diseases. In: Scriver CR, Beaudet AL, Sly WS, Valle MD, eds. The metabolic and molecular bases of inherited diseases, 7th ed. New York: McGraw-Hill, 1995:1535-1609.
2. Pearson HA, Lobel JS, Kocoshis SA, et al. A new syndrome of refractory sideroblastic anemia with vacuolization of marrow precursor and exocrine pancreatic dysfunction. J Pediatr 1979;95:976-984.
3. McShane MA, Hammans SR, Sweeney M, et al. Pearson syndrome and mitochondrial encephalomyopathy in a patient with a deletion of mtDNA. Am J Hum Genet 1991;48:39-42.
4. Rötig A, Bourgeron T, Chretien D, Rustin P, Munnich A. Spectrum of mitochondrial DNA rearrangements in the Pearson marrow-pancreas syndrome. Hum Mol Genet 1995;4:1327-1330.
5. Leigh D. Subacute necrotizing encephalomyelopathy in an infant. J Neurol Neurosurg Psychiatry 1951;14:216-221.
6. Blatt J, Katerji A, Barmada M, Wenger S, Penchansky L. Pancytopenia and vacuolation of marrow precursors associated with necrotizing encephalopathy. Br J Haematol 1994;86: 207-209.
7. Di Mauro S, Servidei S, Zeviani M, et al. Cytochrome c oxidase in Leigh syndrome. Ann Neurol 1987;22:498-506.
8. Vazquez-Memije ME, Shanske S, Santorelli FM, et al. Comparative biochemical studies in fibroblasts from patients with different forms of Leigh syndrome. J Inherit Metab Dis 1996; 19:43-50.
9. Zeviani M, Moraes CT, DiMauro S, et al. Deletions of mitochondrial DNA in Kearns-Sayre syndrome. Neurology 1988; 38:1339-1346.
10. Mita S, Rizzuto R, Moraes CT, et al. Recombination via flanking direct repeats is a major cause of large-scale deletions of human mitochondrial DNA. Nucleic Acids Res 1990;18:561-567.
11. Smith OP, Hann IM, Woodward CE, Brockington M. Pearson's marrow/pancreas syndrome: haematological features associated with deletion and duplication of mitochondrial DNA. Br J Haematol 1995;90:469-472.
12. Poulton J, Deadman ME, Bindoff L, Morten K, Land J, Brown G. Families of mtDNA re-arrangements can be detected in patients with mtDNA deletions: duplications may be a transient intermediate form. Hum Mol Genet 1993;2:23-30.
13. Blaw ME, Mize CE. Juvenile Pearson syndrome. J Child Neurol 1990;5:187-190.
14. Yamadori I, Kurose A, Kobayashi S, Ohmori M, Imai T. Brain lesions of the Leigh-type distribution associated with a mitochondropathy of Pearson's syndrome: light and electron microscopic study. Acta Neuropathol (Berl) 1992;84:337-341.
15. Sparaco M, Bonilla E, DiMauro S, Powers JM. Neuropathology of mitochondrial encephalomyopathies due to mitochondrial DNA defects. J Neuropathol Exp Neurol 1993;52:1-10.